Skip to main content
. 2021 Jan 4;14:4. doi: 10.1186/s40545-020-00279-3

Table 3.

Healthcare resource utilisation in control and intervention group patients at baseline and at 6-month follow-up

Outcome measures Control Intervention p value
Baseline
(6 months pre-study)
6-month follow-up Difference# Baseline
(6 months pre-study)
6-month follow-up Difference#
n = 161*
(48.8%)
n = 161*
(48.8%)
n = 169*
(51.2%)
n = 169*
(51.2%)
Number of unplanned hospital admissions (total) 46 33 40 21
 Mean ± SD 0.3 ± 0.67 0.2 ± 0.58 0.1 ± 0.8 0.2 ± 0.51 0.1 ± 0.40 0.1 ± 0.6

0.279b

0.023c

0.501d

 Median [IQR] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0]
Number of patients admitted (total) 34 24 34 17
Length of stay (days) (total) 148 97 - 118 74 -
 Mean ± SD 4.4 ± 4.4 4.0 ± 3.9 - 3.5 ± 4.1 4.4 ± 3.8 - 0.733e
 Median [IQR] 3.0 [1.0–7.0] 2.5 [1.0–6.5] - 1.5 [1.0–4.3] 3.0 [1.0–7.5] -
Number of A&E attendances (total) 45 57 43 37
 Mean ± SD 0.3 ± 0.6 0.4 ± 0.8 -0.1 ± 0.9 0.3 ± 0.5 0.2 ± 0.4 0.0 ± 0.6

0.326b

0.433c

0.333d

 Median [IQR] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0] 0 [0–0]
Number of face-to-face consultations in general practicea (total) 827 741 791 722
 Mean ± SD 5.1 ± 4.2 4.6 ± 3.8 0.5 ± 3.9 4.7 ± 3.4 4.3 ± 3.4 0.4 ± 3.4

0.087b

0.069c

0.953d

 Median [IQR] 4 [2–7] 4 [2–6] 1 [-2–1] 4 [2–7] 4 [2–6] 1 [-2–2.5]
Number of telephone consultations in general practicea (total) 300 300 321 239
 Mean ± SD 1.9 ± 3.1 1.9 ± 2.9 0.0 ± 2.6 1.9 ± 2.7 1.4 ± 2.0 0.5 ± 2.4

0.481b

0.006c

0.020d

 Median [IQR] 1 [0–2] 1 [0–3] 0 [-1–1] 1 [0–3] 1 [0–2] 0 [0–1]
Total (face and telephone) number of General Practice consultationsa 1127 1041 1112 961
 Mean ± SD 7.0 ± 5.9 6.5 ± 5.3 0.5 ± 5.1 6.6 ± 4.9 5.7 ± 4.3 0.9 ± 4.4

0.284b

0.007c

0.227d

 Median [IQR] 6 [3–9] 5 [3–9] 0 [− 2–3] 6 [3–9] 5 [2–8] 1 [− 2–4]
Number of outpatient visits (total) 453 453 487 430
Mean ± SD 2.8 ± 2.9 2.8 ± 2.9 0.0 ± 2.3 2.9 ± 3.1 2.5 ± 3.1 0.3 ± 2.6

0.841b

0.074c

0.136d

Median [IQR] 2 [1–4] 2 [0–4] 0 [− 1–1] 2 [1–4] 2 [0–4] 0 [− 1–2]

Bold values denote statistical significance at the p < 0.05 level

*From 356 patients, 14 patients’ healthcare resource utilisation data were not available, seven patients were deceased, five patients had 20 or more days of length of stay at baseline or 6-month follow-up

#Calculated as utilisation at baseline minus utilisation at end of study

aConsultation with general practitioner, pharmacist and nurse practitioner

bWilcoxon signed rank test (within control group, between baseline and 6-month follow-up)

cWilcoxon signed rank test (within intervention group, between baseline and 6-month follow-up)

dMann–Whitney U test (between control vs intervention for the utilisation difference from baseline)

eMann–Whitney U test (between control vs intervention at 6-month follow-up)